Multiple myeloma remains an incurable disease although the Ball - Nets prognosis has been improved by novel therapeutics and agents recently.Relapse occurs in the majority of patients and becomes fatal finally.Immunotherapy might be a powerful intervention to maintain a long-lasting control of minimal residual disease or to even eradicate dissemina
Serum metabolic signatures for acute pulmonary embolism identified by untargeted metabolomics
Background and aimsThe important metabolic features of acute pulmonary embolism (APE) risk stratification and their underlying biological basis remain elusive.Our study aims to develop early diagnostic models and classification models by analyzing the plasma metabolic profile of patients with APE.Materials and methodsSerum samples were collected fr
Graph modelling for tracking the COVID-19 pandemic spread
The modelling is widely used in determining the best strategies for the mitigation of the impact of infectious diseases.Currently, the modelling of a complex system such as the spread of COVID-19 infection is among the topical issues.The aim of this article is graph-based modelling of the Shoes COVID-19 infection spread.The article investigates the
An Investigation Of Roof Garden Design Criteria
Storage With the effects inflicted by irregular development and growth of built environment that started to form towards the end of the 20th century, green areas started to lose their original function and started to decrease.Higher cost of land in urban areas have led to a re-evaluation of the usable space on building roofs.Accordingly, the number
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations.
Minor histocompatibility (H) antigens are allogeneic target molecules having significant roles in alloimmune responses after human leukocyte antigen-matched solid organ and stem cell transplantation (SCT).Minor H antigens are instrumental in the processes of transplant rejection, graft-versus-host disease, and in the curative graft-versus-tumor eff